BioSpace News Archive

A new research report titled “Global Bictegravir market” successfully exhibits the complete scenario of the global and an individual analysis of the various regional segments.

A new research report titled “Global Antihyperuricemic Agents market” successfully exhibits the complete scenario of the global and an individual analysis of the various regional segments.

With the noticeable surge in the incidence rate of human immunodeficiency virus -1 infection, the market for HIV therapeutics market is gaining remarkable momentum across the world.

Wilmington, Delaware, United States: According to Transparency Market Research’s latest report on the global diabetes devices market for the historical period 2017–2018 and forecast period 2019–2027, increase in prevalence of diabetes, and increase in adoption of insulin pumps among type 1 diabetes patients are projected to drive the global diabetes devices market during the forecast period.

Wilmington, Delaware, United States: The surgical lighting systems market is likely to witness promising growth across the forecast period of 2021-2031 owing to the rising incidences of lifestyle disorders across the globe.

Wilmington, Delaware, United States: The increasing number of cases of minimally invasive surgical procedures is projected to aid in the expansion of the global radiofrequency ablation devices market.

A precedent-setting prevention trial in Colombia has found that the investigational medicine crenezumab did not slow or prevent decline in cognition or memory for cognitively healthy people with a rare genetic mutation that causes early-onset Autosomal Dominant Alzheimer’s Disease.

Hansa Biopharma, “Hansa”, pioneer in enzyme technology for rare immunological conditions, announces the recommendation by the National Institute for Health and Care Excellence for its first-in-class treatment Idefirix® in the desensitization of highly sensitized adult patients prior to kidney transplant from a deceased donor.

DBV Technologies, a clinical-stage biopharmaceutical company, announced that Daniel Tassé, Chief Executive Officer, and Dr. Pharis Mohideen, Chief Medical Officer, will participate in a fireside chat on Thursday, June 16, 2022, at 12:00 p.m. ET at the JMP Securities Life Sciences Conference in New York.

Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring system portfolio and distributor of Eversense® Continuous Glucose Monitoring Systems, announces that its partner Senseonics Holdings, Inc. has received CE Mark approval for the Eversense® E3 Continuous Glucose Monitoring System, clearing the way for its use in European Union member countries.